tiprankstipranks
Trending News
More News >
Clinigence Holdings Inc (NUTX)
:NUTX
US Market

Clinigence Holdings (NUTX) Earnings Dates, Call Summary & Reports

Compare
255 Followers

Earnings Data

Report Date
Aug 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-1.48
Last Year’s EPS
-0.07
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 13, 2025
|
% Change Since: -3.10%
|
Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in patient visits, revenue, and profitability, alongside effective arbitration processes and expansion plans. However, challenges remain in the arbitration process and non-cash expenses impacting financials. Overall, positive progress was reported despite some ongoing challenges.
Company Guidance
During Nutex Health's first-quarter 2025 earnings call, the company reported impressive financial growth and operational progress. Total patient visits increased by 20.5% to 48,269 compared to the previous year, with mature hospitals seeing a 5.3% rise in visits. Financially, the company achieved a 214% surge in total revenue, reaching $211.8 million, driven largely by their arbitration efforts, which contributed $105 million. Adjusted EBITDA rose to $72.8 million from a negative $400,000 in the previous year, while net income reached $14.6 million compared to a $400 million loss. Nutex's cash reserves grew significantly to $87.7 million, and their long-term debt decreased to $20.7 million. The company's focus on enhancing patient volume, optimizing revenue through efficient cycle management and arbitration, and maintaining cost discipline has positioned them well for continued growth. Looking ahead, Nutex plans to open three additional hospitals in 2025 and is considering further expansion through various strategic options, including de novo hospital openings and potential acquisitions.
Significant Increase in Patient Visits
Total patient visits reached 48,269, a 20.5% increase from 40,068 in Q1 2024. Mature hospitals achieved a 5.3% increase in visits.
Record Revenue Growth
Total revenue reached $211.8 million, a 214% increase from $67.5 million in Q1 2024. Hospital division revenue grew by 240%.
Strong Adjusted EBITDA and Net Income
Adjusted EBITDA was $72.8 million, up from a negative $400,000 in Q1 2024. Net income attributable to Nutex Health, Inc. was $14.6 million compared to a $400 million loss in Q1 2024.
Improved Cash Flow and Debt Reduction
Net cash flow from operating activities was $51 million compared to $3.1 million in Q1 2024. Long-term debt reduced to $20.7 million from $22.5 million at year-end 2024.
Effective Arbitration Process
Submitted 60% to 70% of billable visits through arbitration with an 80% win rate, increasing facility collections by 200% to 300% compared to initial insurance payments.
Expansion Plans
Plans to open three additional hospitals in 2025, with a pipeline extending to 2028 for more projects in high-demand markets.

Clinigence Holdings (NUTX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

NUTX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 07, 2025
2025 (Q2)
-1.48 / -
-0.07
May 13, 2025
2025 (Q1)
- / 2.56
-0.12660.00% (+2.66)
Mar 31, 2025
2024 (Q4)
3.04 / 2.56
-0.12660.00% (+2.66)
Nov 07, 2024
2024 (Q3)
-0.24 / -1.72
-1.5-14.67% (-0.22)
Aug 08, 2024
2024 (Q2)
-0.29 / -0.07
-1.595.33% (+1.43)
May 08, 2024
2024 (Q1)
0.00 / -0.10
-1.593.33% (+1.40)
Mar 28, 2024
2023 (Q4)
0.00 / -7.50
-3-150.00% (-4.50)
Nov 09, 2023
2023 (Q3)
-0.75 / -1.50
-94.598.41% (+93.00)
Aug 09, 2023
2023 (Q2)
-0.75 / -1.50
-4.50266.68% (+3.00)
May 15, 2023
2023 (Q1)
-2.25 / -1.50
-52.0997.12% (+50.59)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

NUTX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 13, 2025
$125.93$158.80+26.10%
Mar 31, 2025
$47.03$71.40+51.82%
Nov 07, 2024
$28.89$31.56+9.24%
Aug 08, 2024
$7.90$10.10+27.85%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Clinigence Holdings Inc (NUTX) report earnings?
Clinigence Holdings Inc (NUTX) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
    What is Clinigence Holdings Inc (NUTX) earnings time?
    Clinigence Holdings Inc (NUTX) earnings time is at Aug 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is NUTX EPS forecast?
          NUTX EPS forecast for the fiscal quarter 2025 (Q2) is -1.48.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis